Payam Kashi, MD

MD, PhD, CRO, Director of Clinical Operations

Translational women’s health research

Gynecologic oncology & minimally invasive surgery

Fertility outcomes & reproductive preservation

Long-term surgical outcomes tracking

Pelvic floor recovery and surgical outcomes

Genetic markers in gynecologic oncology

Biography

Dr. Payam Kashi, MD, PhD, is a biomedical researcher advancing women’s health through translational science and clinical innovation. Trained in reproductive physiology and molecular biology, his work connects groundbreaking discovery with improved surgical and fertility outcomes.

At Annandale OBGYN, Dr. Kashi directs research across gynecology, fertility, and minimally invasive surgery, supporting the practice’s mission to enhance women’s health at every stage of life.

Areas of Research

Minimally Invasive & Robotic Surgery

Dr. Kashi contributes to the advancement of robotic and laparoscopic techniques in gynecologic oncology, including single-site robot-assisted hysterectomy and abdominal cerclage placement. His studies focus on reducing recovery time, operative morbidity, while improving long-term outcomes for women undergoing benign or oncologic procedures.

Sentinel Lymph Node Mapping & Surgical Staging

His research evaluates sentinel lymph node mapping in high-grade endometrial and early-stage vulvar cancers to maintain oncologic safety while minimizing surgical morbidity.

Fertility & Reproductive Outcomes

Dr. Kashi co-authored work on fertility-sparing surgery for cervical, endometrial, and ovarian cancers, aligning surgical innovation with the preservation of reproductive potential.

Quality Improvement & Perioperative Outcomes

He has published on perioperative venous-thromboembolism prevention and universal inpatient palliative-care protocols, emphasizing safety, access, and the overall patient experience in gynecologic oncology.

Selected Publications

Fertility-sparing Surgery for Patients with Cervical, Endometrial, and Ovarian Cancers. 
This study analyzes fertility-sparing strategies across major gynecologic cancers and reports favorable progression-free and overall survival outcomes in appropriately selected patients.
Read the publication on PubMed.

Progestin and Aromatase Inhibitor Therapy in Recurrent ER/PR-Positive Uterine Carcinosarcoma: A Case Report. 
Reports durable disease control in a heavily pre-treated uterine carcinosarcoma using combined endocrine therapy, supporting hormonal management in select ER/PR-positive cases.
Read the publication on PubMed.

Placental Site Trophoblastic Tumor versus Exaggerated Placental Site: A Diagnostic Challenge. 
Highlights histopathologic distinctions between rare trophoblastic entities, emphasizing accurate diagnosis for optimal patient management.
Read the publication on PubMed.

Awards & Recognition

  • Recipient, Excellence in Translational Research Award, Biomedical Research Society
  • Editorial Reviewer, Journal of Reproductive Medicine & Women’s Health
  • Invited Speaker, Annual Conference on Reproductive Innovation

Affiliations & Collaborations

Contact

Researchers, clinicians, and students interested in collaborative projects are invited to contact the Annandale OBGYN research office through payam.kashi@annandaleobgyn.com.

For media inquiries or to request Dr. Kashi’s CV and full list of publications, please email nick.spalding@annandaleobgyn.com.